User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Regression of Sweet's syndrome associated with Crohn's disease after anti-Tumour Necrosis Factor therapy.

Primary tabs

Rahier, Jean-François [MGD] Lion, L [UCL] Dewit, Olivier [UCL] Lambert, Michel [UCL]

The association of inflammatory bowel disease and acute febrile neutrophilic dermatitis (Sweet's syndrome) has infrequently been reported in the literature. We describe the case of a 41-year-old Caucasian woman with ileo- anal Crohn's disease who presented simultaneously an erythema nodosum and a Sweet's syndrome. A dramatic regression of the cutaneous lesions was observed after infliximab treatment, indicating that this therapy might be useful for both Crohn's disease and Sweet's syndrome.

Document type Article de périodique (Journal article) – Case Reports, Journal Article
Access type Accès restreint
Publication date 2005
Journal information "Acta gastro-enterologica Belgica" - Vol. 68, no. 3, p. 376-9 (2005)
Peer reviewed yes
issn 0001-5644
Publication status Publié
Affiliations UCL - (MGD) Service de pneumologie
UCL - (MGD) Service de gastro-entérologie
UCL - MD/MINT - Département de médecine interne
UCL - (SLuc) Service de médecine interne et maladies infectieuses (MIMI)
MESH Subject Adult ; Antibodies, Monoclonal - therapeutic use ; Crohn Disease - blood - complications ; Dermatologic Agents - therapeutic use ; Female ; Follow-Up Studies ; Humans ; Sweet Syndrome - blood - complications - drug therapy ; Tumor Necrosis Factor-alpha - antagonists & inhibitors - metabolism
Links
Bibliographic reference Rahier, Jean-François ; Lion, L ; Dewit, Olivier ; Lambert, Michel. Regression of Sweet's syndrome associated with Crohn's disease after anti-Tumour Necrosis Factor therapy.. In: Acta gastro-enterologica Belgica, Vol. 68, no. 3, p. 376-9 (2005)
Permanent URL http://hdl.handle.net/2078.1/28316